Terapia Ranbaxy To Pay RON205M Dividend From 2011-2013 Profits

03.06.2014 By Florentina Dragu

Romania’s largest generic drug maker Terapia Ranbaxy, the local unit of Indian pharmaceuticals group Ranbaxy Laboratories, will pay out its shareholders a total dividend of 205 million lei (EUR45.6 million) from the profits reported over the last three years, the company said Thursday.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

Keywords:: TERAPIA RANBAXY; , DIVIDEND; ,

Comment

Username:
Password: